UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: B | C | F | G | H | J | L | N | P | R | T | V
Number of items: 20.

B

Begent, RHJ; Chester, KA; Bagshawe, KD; Keep, PAS; F, B; J, B; ... Woodrow, DF; + view all (1989) 2nd antibody for improvement of antibody imaging-liposome-entrapped and free preparations in animal and human studies. Clinical and Experimental Immunology , 78 (2) 307 - 313.

Beyaert, R; Vanhaesebroeck, B; Suffys, P; Van Roy, F; Fiers, W; (1989) Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc Natl Acad Sci U S A , 86 (23) 9494 - 9498.

BISHOP, JAM; JACKMAN, AL; HUGHES, LR; CALVERT, AH; (1989) CROSS-RESISTANCE STUDIES WITH QUINAZOLINE INHIBITORS OF THYMIDYLATE SYNTHASE (TS) AGAINST 2 METHOTREXATE (MTX)-RESISTANT SUBLINES OF THE L1210. BRIT J CANCER , 60 (3) 499 - 499.

BISSET, G; PAWELCZAK, K; JACKMAN, AL; PERKIN, EED; CALVERT, AH; HUGHES, LR; (1989) THE SYNTHESIS AND THYMIDYLATE SYNTHASE (TS) INHIBITORY ACTIVITY OF THE POLY-GAMMA-GLUTAMYL DERIVATIVES OF SOME ANALOGS OF N-10-PROPARGYL-5, 8-DIDEAZAFOLATE (CB3717). BRIT J CANCER , 60 (3) 501 - 502.

C

CALVERT, AH; (1989) A CRITICAL-ASSESSMENT OF CANCER-CHEMOTHERAPY - INTRODUCTION - A HISTORY OF THE PROGRESS OF ANTICANCER CHEMOTHERAPY. CANCER SURV , 8 (3) 493 - 509.

Calvert, AH; (1989) Introduction: a history of the progress of anticancer chemotherapy. Cancer Surv , 8 (3) 493 - 509.

CASSIDY, J; LEWIS, C; SETANOIANS, A; ADAMS, L; KERR, DJ; CALVERT, AH; ... KAYE, SB; + view all (1989) PHASE-1 TRIAL OF GR63178A. BRIT J CANCER , 60 (3) 457 - 457.

Chester, KA; Primrose, L; Pringle J H, T; I C, B; R H J, M; A, BD; (1989) Evaluation of messenger-RNA sequences from the human-colon which show differential expression in normal and neoplastic mucosa. In: Journal of Pathology. (pp. A169 - A169).

F

FOSTER, BJ; NEWELL, DR; CARMICHAEL, J; HARRIS, AL; GUMBRELL, LA; WILMAN, DEV; CALVERT, AH; (1989) PRECLINICAL AND CLINICAL PHARMACOKINETIC STUDIES WITH 1-(4-CARBOXYPHENYL)-3, 3-DIMETHYL TRIAZENE (CB10-277). BRIT J CANCER , 60 (3) 464 - 464.

G

GORE, ME; FRYATT, I; WILTSHAW, E; DAWSON, T; ROBINSON, BA; CALVERT, AH; (1989) CISPLATIN CARBOPLATIN CROSS-RESISTANCE IN OVARIAN-CANCER. BRIT J CANCER , 60 (5) 767 - 769.

GRAHAM, MA; NEWELL, DR; FOSTER, BJ; CALVERT, AH; (1989) THE PHARMACOKINETICS AND TOXICITY OF THE ANTHRAPYRAZOLE ANTI-CANCER DRUG CI-941 IN THE MOUSE - A GUIDE FOR RATIONAL DOSE ESCALATION IN PATIENTS. CANCER CHEMOTH PHARM , 23 (1) 8 - 14.

H

HARRAP, KR; JACKMAN, AL; NEWELL, DR; TAYLOR, GA; HUGHES, LR; CALVERT, AH; (1989) THYMIDYLATE SYNTHASE - A TARGET FOR ANTICANCER DRUG DESIGN. ADV ENZYME REGUL , 29 161 - 179.

J

JONES, TR; BETTERIDGE, RF; NEIDLE, S; JACKMAN, AL; CALVERT, AH; (1989) QUINAZOLINE ANTIFOLATES INHIBITING THYMIDYLATE SYNTHASE - COMPUTER MODELING OF THE N-10 SUBSTITUENT. ANTI-CANCER DRUG DES , 3 (4) 243 - 248.

JUDSON, IR; CALVERT, AH; RUTTY, CJ; ABEL, G; GUMBRELL, LA; GRAHAM, MA; ... CAIRNDUFF, F; + view all (1989) PHASE-I TRIAL AND PHARMACOKINETICS OF TRIMELAMOL (N-2,N-4,N-6-TRIHYDROXYMETHYL-N-2,N-4,N-6-TRIMETHYLMELAMINE). CANCER RES , 49 (19) 5475 - 5479.

L

Lee, SM; Wong, NW; Rathakrishnan, V; (1989) Are we missing portal vein thrombosis? Singapore Medical Journal , 30 (4) 388 - 389.

N

NEWELL, DR; GUMBRELL, LA; BOXALL, FE; EELES, RA; HORWICH, A; CALVERT, AH; (1989) CARBOPLATIN DOSE DETERMINATION USING A SIMPLE FORMULA - SINGLE AGENT, COMBINATION AND HIGH-DOSE STUDIES. BRIT J CANCER , 60 (3) 463 - 464.

P

PEDLEY, RB; BODEN, JA; BODEN, RW; GREEN, A; BOXER, GM; BAGSHAWE, KD; (1989) THE EFFECT OF SERUM CEA ON THE DISTRIBUTION AND CLEARANCE OF ANTI-CEA ANTIBODY IN A PANCREATIC TUMOR XENOGRAFT MODEL. BRIT J CANCER , 60 (4) 549 - 554.

R

Reszka, K; Hartley, JA; Kolodziejczyk, P; Lown, JW; (1989) Interaction of the peroxidase-derived metabolite of mitoxantrone with nucleic acids. Evidence for covalent binding of 14C-labeled drug. Biochem Pharmacol , 38 (23) 4253 - 4260.

T

THORNTON, TJ; JACKMAN, AL; OCONNOR, B; BISHOP, J; HUGHES, L; CALVERT, AH; (1989) SYNTHESIS AND SOME BIOLOGICAL PROPERTIES OF QUINAZOLINE ANTIFOLATES VARIOUSLY SUBSTITUTED WITH FLUORINE ON THE BENZOYL RING. BRIT J CANCER , 60 (3) 501 - 501.

V

Vanhaesebroeck, B; Grooten, J; Fiers, W; (1989) An ongoing in vivo immune response affects the abundancy and differentiation of lymphokine-activated killer cell precursors, but does not influence their broad spectrum target reactivity. J Immunol , 143 (4) 1396 - 1402.

This list was generated on Mon Dec 22 10:47:05 2014 GMT.